Use este identificador para citar ou linkar para este item:
http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/1834
Registro completo de metadados
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | Seixas, Regina Cele Silveira | en_US |
dc.contributor.author | Balbino, Marcos | en_US |
dc.contributor.author | Basile Neto, Alberto | en_US |
dc.contributor.author | Costa, Amanda de Alcantara Almeida | en_US |
dc.contributor.author | Jordão, Marcelo Lopes da Silva | en_US |
dc.contributor.author | Russ, Heloisa Helena Abil | en_US |
dc.date.accessioned | 2024-06-26T15:20:21Z | - |
dc.date.available | 2024-06-26T15:20:21Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Seixas, Regina Cele Silveira. Mid-term evaluation of istent inject® trabecular micro-bypass stent implantation with or without phacoemulsification: a retrospective study. Clinical ophthalmology, v. 14, p. 4403–4413, 2020. | en_US |
dc.identifier.issn | 1177-5483 | - |
dc.identifier.uri | http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/1834 | - |
dc.description.abstract | Introduction: This study evaluated the 6-month performance and safety of micro-invasive glaucoma surgery (MIGS) with iStent inject either with or without cataract surgery. Material and Methods: Longitudinal retrospective study of 86 surgeries in 49 patients with inadequately controlled open-angle glaucoma (OAG) or ocular hypertension who underwent iStent inject trabecular micro-bypass implantation either alone (isolated group) or combined with cataract surgery (combined group). The two primary outcomes included an intraocular pressure (IOP) drop of ≥20% versus preoperative values (adequate drop) and IOP maintenance between 6 and 18 mmHg (adequate Range). For both outcomes, we determined “complete” and “qualified” success if patients did not require or did require glaucoma medications, respectively, at the end of follow-up. Safety outcomes included best-corrected visual acuity, adverse events, and secondary surgeries. Results: In the adequate drop analysis, 30.2% achieved “complete success,” and 37.2% achieved “qualified success.” For adequate range, 40.7% achieved “complete success” and 39.5% achieved “qualified success.” There was no difference in medication decrease (p=0.77) nor IOP reduction (p=0.46) between the isolated and combined groups. Safety was generally favorable and similar between groups, with mild transient adverse events that resulted in no sequelae.Discussion/Conclusion: iStent inject implantation either with or without cataract surgery was able to safely decrease IOP and medication requirements through 6 months after surgery | - |
dc.publisher | Dove Medical Press Ltd | en_US |
dc.relation.ispartof | Clinical ophthalmology, v. 14, 2020 | en_US |
dc.subject | Glaucoma | en_US |
dc.subject | Terapêutica | en_US |
dc.subject | Glaucoma - cirurgia | en_US |
dc.subject | Catarata - cirurgia | en_US |
dc.title | Mid-term evaluation of istent inject® trabecular micro-bypass stent implantation with or without phacoemulsification: a retrospective study | en_US |
dc.type | Artigo de Periódico | en_US |
dc.identifier.doi | 10.2147/OPTH.S283587 | - |
Aparece nas coleções: | Artigos de Periódicos |
Arquivos associados a este item:
Arquivo | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Marcos Balbino - Mid-term evaluation of istent.pdf | 3.27 MB | Adobe PDF | Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.